Drugs / SYR-322
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02276274 | Jun 2014 | — | Takeda | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SYR-322 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02276274 ↗ |
| Route | Oral | “is orally administered” NCT02276274 ↗ |